Addressing Treatment Challenges in Growth Hormone Deficiency With Novel Long-Acting Therapies

Join us for a live hybrid event where leading experts will provide insight and tools for endocrinology specialists to address the treatment challenges in growth hormone deficiency. Esteemed faculty will discuss the available and emerging treatment options in pediatric and adult patients as well as providing insights in overcoming challenges with long-term GHD management.

Share

Program Content

Activities

Treatment in  GHD With Long-Acting Therapies
Addressing Treatment Challenges in Growth Hormone Deficiency With Novel Long-Acting Therapies
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 13, 2023

Activities

Growth Hormone Deficiency
Addressing Treatment Challenges in Growth Hormone Deficiency With Novel Long-Acting Therapies
Video
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2023

Expires: December 31, 2024

Activities

Questions and Answers on GHD
Questions and Answers From the ENDO 2023 Symposium: Addressing Treatment Challenges in Growth Hormone Deficiency With Novel Long-Acting Therapies
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 11, 2023

Expires: July 11, 2024

Strategies to Incorporate LAGH Therapy
Incorporating Long-Acting Growth Hormone Therapy Into Practice
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 26, 2023

Expires: July 26, 2024

LAGH Therapy in Pediatrics
Long-Acting Growth Hormone Therapy: Best Practices for Pediatrics
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 14, 2023

Expires: August 14, 2024

Provided by

ProCE Banner
ProCE Banner

Jointly provided by Clinical Care Options, LLC and Endocrine Society

Supporters

This activity is supported by an educational grant from Novo Nordisk.

Novo Nordisk